Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership1,581 shares
Latest Disclosed Value $ 224,233
Parallel Advisors, LLC ownership in NBIX / Neurocrine Biosciences, Inc.

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 1,581 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $224,233 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 1,632 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -3.12% during the quarter.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,581 -51 -3.12 224 -2.18 0.0041
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,632 41 2.58 229 15.08 0.0042
2025-07-08 2025-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,591 212 15.37 200 30.92 0.0040
2025-04-08 2025-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,379 -632 -31.43 153 -44.53 0.0034
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 2,011 172 9.35 275 29.86 0.0062
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,839 140 8.24 212 -9.44 0.0050
2024-08-08 2024-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,699 12 0.71 234 0.43 0.0060
2024-05-06 2024-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,687 151 9.83 233 14.85 0.0063
2024-02-12 2023-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,536 -308 -16.70 202 -2.42 0.0060
2024-05-20 2023-09-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,844 713 63.04 207 95.28 0.0069
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,844 713 207 0.0069
2024-05-20 2023-06-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,131 88 8.44 107 0.95 0.0034
2023-08-04 2023-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,131 88 107 0.0034
2024-05-20 2023-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,043 79 8.20 106 -8.70 0.0036
2023-04-25 2023-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 1,043 79 106 0.0036
2023-02-06 2022-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 964 123 14.63 115 29.21 0.0050
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 841 256 43.76 89 56.14 0.0041
2022-08-01 2022-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 585 -54 -8.45 57 -3.39 0.0026
2022-04-28 2022-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 639 175 37.72 59 47.50 0.0023
2022-01-20 2021-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 464 1 0.22 40 -9.09 0.0015
2021-11-02 2021-09-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 463 261 129.21 44 120.00 0.0018
2021-08-06 2021-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 202 27 15.43 20 17.65 0.0008
2021-04-23 2021-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 175 3 1.74 17 6.25 0.0008
2021-02-02 2020-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 172 -1 -0.58 16 -5.88 0.0009
2020-10-27 2020-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 173 29 20.14 17 0.00 0.0011
2020-07-16 2020-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 144 -19 -11.66 17 21.43 0.0011
2020-04-27 2020-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 163 4 2.52 14 -17.65 0.0011
2020-01-30 2019-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 159 0 0.00 17 21.43 0.0013
2019-11-01 2019-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 159 31 24.22 14 27.27 0.0012
2019-08-05 2019-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 128 0 0.00 11 0.00 0.0011
2019-05-01 2019-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 128 0 0.00 11 22.22 0.0012
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 128 -6 -4.48 9 -43.75 0.0013
2018-11-01 2018-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 134 0 0.00 16 23.08 0.0020
2018-07-30 2018-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 134 36 36.73 13 62.50 0.0019
2018-05-08 2018-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 98 0 0.00 8 0.00 0.0012
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 98 0 0.00 8 14.29 0.0013
2017-11-15 2017-09-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 98 9 10.11 7 75.00 0.0012
2017-08-07 2017-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 89 0 0.00 4 -20.00 0.0008
2017-05-12 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 89 9 11.25 5 66.67 0.0010
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 89 5
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 80 80 3 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock Call 202 20 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.